ICU Medical will present at the J.P. Morgan Healthcare Conference on January 15, 2025, including live webcasting.
Quiver AI Summary
ICU Medical, a leading developer of innovative medical products, announced that its management will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco from January 13-16, 2025. The presentation is scheduled for January 15 at 10:30 a.m. PT and will be webcast live on the company's website. Additionally, management will participate in one-on-one meetings on January 15 and 16. ICU Medical specializes in infusion systems and critical care products, serving various healthcare settings globally, and is headquartered in San Clemente, California. More information about the company can be found on its website.
Potential Positives
- ICU Medical will present at the prestigious 43rd Annual J.P. Morgan Healthcare Conference, which offers significant exposure to investors and industry leaders.
- The live webcast of the presentation allows for broader reach and engagement with stakeholders who are unable to attend in person.
- Participation in one-on-one meetings at the conference indicates proactive efforts to strengthen investor relations and potentially secure new partnerships or investments.
Potential Negatives
- None
FAQ
When will ICU Medical present at the J.P. Morgan Healthcare Conference?
ICU Medical will present on Wednesday, January 15, 2025, at 10:30 a.m. PT (1:30 p.m. ET).
How can I watch the ICU Medical presentation online?
The presentation will be webcast live on the ICU Medical website under the Investors tab, then Event Calendar.
What is the focus of ICU Medical's product offerings?
ICU Medical specializes in infusion systems, consumables, and critical care products for hospital and home care settings.
Where is ICU Medical headquartered?
ICU Medical is headquartered in San Clemente, California.
Who can I contact for more information about ICU Medical?
You can contact Brian Bonnell, CFO, at (949) 366-2183 or John Mills, Managing Partner, at (646) 277-1254.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ICUI Congressional Stock Trading
Members of Congress have traded $ICUI stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ICUI stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 10/31.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ICUI Insider Trading Activity
$ICUI insiders have traded $ICUI stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $ICUI stock by insiders over the last 6 months:
- VIVEK JAIN (Chairman and CEO) has traded it 16 times. They made 0 purchases and 16 sales, selling 61,373 shares.
- DANIEL WOOLSON (VP, GM-Infusion Capital) has traded it 2 times. They made 0 purchases and 2 sales, selling 4,743 shares.
- DAVID C. GREENBERG sold 972 shares.
- CHRISTIAN B. VOIGTLANDER (Chief Operating Officer) has traded it 4 times. They made 0 purchases and 4 sales, selling 11,111 shares.
- VIRGINIA RUTH SANZONE (VP, General Counsel) sold 2,050 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ICUI Hedge Fund Activity
We have seen 155 institutional investors add shares of $ICUI stock to their portfolio, and 99 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 505,290 shares (-35.0%) from their portfolio in Q3 2024
- CITADEL ADVISORS LLC added 447,512 shares (+217.4%) to their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC added 402,035 shares (+295.5%) to their portfolio in Q3 2024
- BLACKROCK, INC. added 398,609 shares (+12.3%) to their portfolio in Q3 2024
- SILVERCREST ASSET MANAGEMENT GROUP LLC removed 386,753 shares (-50.4%) from their portfolio in Q3 2024
- NEUBERGER BERMAN GROUP LLC removed 151,838 shares (-25.4%) from their portfolio in Q3 2024
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO removed 150,418 shares (-99.1%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
SAN CLEMENTE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 43
rd
Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ICU Medical’s presentation will be on Wednesday, January 15, 2025 at 10:30 a.m. PT (1:30 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, January 15, 2025 and Thursday, January 16, 2025.
The presentation will be webcast live and can be accessed by going to the Company’s website at
http://www.icumed.com
, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.
About ICU Medical
ICU Medical (Nasdaq:ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at
www.icumed.com
.
CONTACT:
ICU Medical
Brian Bonnell, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Managing Partner
(646) 277-1254
Source: ICU Medical, Inc.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.